Biological Features of Gastric Cancer After Neoadjuvant Chemotherapy
Our study suggests that the lack of NAC response to DS/DCS therapy is associated with increased tumor proliferation, a poor antitumor immune response, and the reduced expression of these five genes (ZNF296, RASSF10, EXOC3L1, KIAA0895 and GALNTL1). These genes represent promising candidates for further investigation as biomarkers for predicting treatment efficacy and as novel therapeutic targets.
Authors
- Masanori Oshi
- Yuko Tamura
- CHIKARA KUNISAKI
- SHO SATO
- TAKASHI KOSAKA
- ITARU ENDO
- HIROKI KONDO
- KOHEI KASAHARA
- HIROTOSHI AKIYAMA
Institutions
- Yokohama City University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-12-30
- DOI
- https://doi.org/10.21873/anticanres.17937
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00